694 related articles for article (PubMed ID: 19250137)
1. Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.
Arpino PA; Thompson BT
J Clin Pharm Ther; 2009 Apr; 34(2):171-5. PubMed ID: 19250137
[TBL] [Abstract][Full Text] [Related]
2. The use of enteral naloxone to treat opioid-induced constipation in a pediatric intensive care unit.
Tofil NM; Benner KW; Faro SJ; Winkler MK
Pediatr Crit Care Med; 2006 May; 7(3):252-4. PubMed ID: 16575353
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
4. Enteral naloxone reduces gastric tube reflux and frequency of pneumonia in critical care patients during opioid analgesia.
Meissner W; Dohrn B; Reinhart K
Crit Care Med; 2003 Mar; 31(3):776-80. PubMed ID: 12626983
[TBL] [Abstract][Full Text] [Related]
5. Nalmefene for elective reversal of procedural sedation in children.
Chumpa A; Kaplan RL; Burns MM; Shannon MW
Am J Emerg Med; 2001 Nov; 19(7):545-8. PubMed ID: 11698998
[TBL] [Abstract][Full Text] [Related]
6. Clinical sedation scores as indicators of sedative and analgesic drug exposure in intensive care unit patients.
Masica AL; Girard TD; Wilkinson GR; Thomason JW; Truman Pun B; Nair UB; Light RW; Canonico AE; Dunn J; Pandharipande P; Shintani AK; Ely EW
Am J Geriatr Pharmacother; 2007 Sep; 5(3):218-31. PubMed ID: 17996661
[TBL] [Abstract][Full Text] [Related]
7. [Effect of enteral naloxone on the incidence of gastritis and esophagitis in mechanically ventilated patients].
Meissner W; Hartmann M; Kähler G; Brauer M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2004 Sep; 39(9):538-41. PubMed ID: 15334330
[TBL] [Abstract][Full Text] [Related]
8. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
9. Enteral naloxone for the treatment of opioid-induced constipation in the medical intensive care unit.
Gibson CM; Pass SE
J Crit Care; 2014 Oct; 29(5):803-7. PubMed ID: 24866021
[TBL] [Abstract][Full Text] [Related]
10. Methylnaltrexone Versus Naloxone for Opioid-Induced Constipation in the Medical Intensive Care Unit.
Merchan C; Altshuler D; Papadopoulos J
Ann Pharmacother; 2017 Mar; 51(3):203-208. PubMed ID: 28168885
[TBL] [Abstract][Full Text] [Related]
11. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
[TBL] [Abstract][Full Text] [Related]
12. [Treament of morphine-induced constipation with oral naloxone].
Latasch L; Zimmermann M; Eberhardt B; Jurna I
Anaesthesist; 1997 Mar; 46(3):191-4. PubMed ID: 9163262
[TBL] [Abstract][Full Text] [Related]
13. An ultra-low dose of naloxone added to lidocaine or lidocaine-fentanyl mixture prolongs axillary brachial plexus blockade.
Movafegh A; Nouralishahi B; Sadeghi M; Nabavian O
Anesth Analg; 2009 Nov; 109(5):1679-83. PubMed ID: 19843808
[TBL] [Abstract][Full Text] [Related]
14. Naloxone reversal of opioid anesthesia revisited: clinical evaluation and plasma concentration analysis of continuous naloxone infusion after anesthesia with high-dose fentanyl.
Takahashi M; Sugiyama K; Hori M; Chiba S; Kusaka K
J Anesth; 2004; 18(1):1-8. PubMed ID: 14991468
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children.
Darnell CM; Thompson J; Stromberg D; Roy L; Sheeran P
Pediatrics; 2008 May; 121(5):e1363-71. PubMed ID: 18411237
[TBL] [Abstract][Full Text] [Related]
16. Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study.
Hermanns K; Junker U; Nolte T
Expert Opin Pharmacother; 2012 Feb; 13(3):299-311. PubMed ID: 22224497
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a premedication algorithm for nonemergent intubation in a neonatal intensive care unit.
VanLooy JW; Schumacher RE; Bhatt-Mehta V
Ann Pharmacother; 2008 Jul; 42(7):947-55. PubMed ID: 18594052
[TBL] [Abstract][Full Text] [Related]
18. Low-dose oral naloxone reverses opioid-induced constipation and analgesia.
Liu M; Wittbrodt E
J Pain Symptom Manage; 2002 Jan; 23(1):48-53. PubMed ID: 11779668
[TBL] [Abstract][Full Text] [Related]
19. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Freye E; Neruda B; Smith OW
Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
[TBL] [Abstract][Full Text] [Related]
20. [Development of continuous monitoring of spontaneous respiration in the postoperative phase. 2. Cutaneous oxygen and carbon dioxide partial pressures following i.v. bolus application of fentanyl, buprenorphine, naloxone and amiphenazole in healthy adult subjects].
Lehmann KA; Huttarsch H; Schroeder B; Zech D
Anaesthesist; 1992 Apr; 41(4):192-8. PubMed ID: 1350432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
